AN2 Therapeutics, Inc. ($ANTX)
Readnour Robin Shane โ Director
Shares
18,706
Price
$6.01
Total Value
$112,389.39
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Readnour Robin Shane |
|---|---|
| Title | Director |
| Transaction Date | Aug 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Indirect |
| Nature of Ownership | See footnotes |
| Filing Date | Aug 19, 2026 |
| Shares Sold | 18,706 |
| Price per Share | $6.01 |
| Total Value | $112,389.39 |
| Shares Owned After | 633,867 |
| Derivative | No |
| Accession Number | 0001193125-26-357225 |
| Document | View SEC Filing |